Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03377023 |
|---|---|
| Brief Title: | Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer |
| First Submitted : | December 13, 2017 |
| First Submitted that Met QC Criteria : | December 13, 2017 |
| First Posted : | December 19, 2017 |
| Last Update Submitted that Met QC Criteria : | November 22, 2022 |
| Last Update Posted : | November 25, 2022 |